American Journal of Advanced Drug Delivery Open Access

  • ISSN: 2321-547X
  • Journal h-index: 22
  • Journal CiteScore: 9.36
  • Journal Impact Factor: 5.76
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Commentary - (2023) Volume 11, Issue 4

Liposomes as Carriers of Anticancer Medicines
Roblot Treupel*
 
Department of Medical Sciences, California University, USA
 
*Correspondence: Roblot Treupel, Department of Medical Sciences, California University, USA, Email:

Received: 29-Nov-2023, Manuscript No. IPAAD-23-18636; Editor assigned: 01-Dec-2023, Pre QC No. IPAAD-23-18636; Reviewed: 15-Dec-2023, QC No. IPAAD-23-18636; Revised: 20-Dec-2023, Manuscript No. IPAAD-23-18636; Published: 27-Dec-2023, DOI: 110.36648/2321-547X.11.4.35

Description

Immune systems have an uneasy relationship with the environment. Most of the time an encounter with something new is harmless, but the small fraction of times that it is not can be very dangerous indeed. An effective immune system must be able to discriminate such differences, distinguishing self from non-self and distinguishing harmless non-self from dangerous non-self. For much of the 20th Century, research in immunology was focused on understanding how it achieved the former. It was spurred by an important early observation that it was possible for animals to develop specific immune reactions against chemicals such as dyes, which had never existed in Nature. The ability to learn how to recognize these previously unknown structures implied that the immune system had solved the problem of how to classify and recall the shapes of individual molecules. Unravelling the biological machinery that achieves this was a signature achievement of 20th Century immunology. This remarkable flexibility underlines the fact that the immune system interrogates the fundamental building blocks of the environment. A process of recognition at a near molecular scale allows the immune system to exploit the fact that all organisms are defined by proteins encoded in their genes. A measles virus is made of different proteins from those of a rabies virus. An Escherichia coli bacterium has a different structure from that of a spirochaete. By classifying the environment in terms of the proteins it contains, and by continuously sampling these proteins, the immune system executes a very active form of monitoring that it links to a stringent verification process and which must incorporate an ability to learn. As part of a defence against a potentially dangerous environment, each individual develops their own unique immune system, which acknowledges only itself. Everything that is not recognized might be a threat.

The immune system’s ability to adapt flexibly to strange environmental changes is critical in fighting infections and cancer. Because our bodies have a remarkable capacity for renewal, and almost every cell is a factory working day and night to turn over worn out molecules, breaking them down into building blocks that are reused to make replacements, infection or cancer can arise at any time. Every time a cell divides, there is a small chance that it may develop a random unpredictable mutation that will transform it into a cancer. Infections reproduce much more rapidly than their hosts and can change their appearance to allow them to evade recognition. An effective immune system must cope with this unpredictability.

We can picture this as an ongoing evolution of the environment and it presents a special challenge for an immune system. In contrast with most organs, such as the heart, which does the same job throughout life, the immune system needs to adapt to an environment that is always changing. This problem is solved by investing in strategies that exploit the power of random change itself. Using randomness in this way creates waste, but preserves responsiveness. Even identical twins, which share the same genes, have immune systems that become increasingly different from each other from birth to old age, as each twin independently makes hundreds of thousands of unique random responses to the environment. In meeting all of these kinds of assault, there is a middle path that an immune response must keep to, between too much destruction and not enough. In this zone, it is quite ruthless in sacrificing itself to terminate an infection.

Conclusion

When common cold viruses have hijacked cells in the throat to replicate, these virus factories are not rehabilitated, but destroyed by killer cells. Where a bacterium has penetrated the skin and established a viable colony, suicidal white blood cells fill the area with bleach that they make themselves, killing indiscriminately and leaving behind a wasteland of debris that needs to be engulfed, digested and processed by the immune system.

Acknowledgement

None.

Conflict Of Interest

The author’s declared that they have no conflict of interest.

Citation: Treupel R (2023) Liposomes as Carriers of Anticancer Medicines. Am J Adv Drug Deliv. 11:35.

Copyright: © 2023 Treupel R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.